Last reviewed · How we verify
Investigators choice single agent — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Investigators choice single agent (Investigators choice single agent) — Celgene.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Investigators choice single agent TARGET | Investigators choice single agent | Celgene | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Investigators choice single agent CI watch — RSS
- Investigators choice single agent CI watch — Atom
- Investigators choice single agent CI watch — JSON
- Investigators choice single agent alone — RSS
Cite this brief
Drug Landscape (2026). Investigators choice single agent — Competitive Intelligence Brief. https://druglandscape.com/ci/investigators-choice-single-agent. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing